Azacitidine Articles
UK’s NICE reverses earlier decision, clearing Celgene’s MDS drug Vidaza for NHS use
17 February 2011
Australia’s fight against cancer continues with new additions to the PBS, says health minister
10 December 2010
UK’s NICE decides to re-appraise Celgene’s MDS drug Vidaza; move welcomed by patients’ group
27 July 2010
Petition calling for cancer drug Vidaza to be made available on the NHS presented to new UK Prime Minister
17 May 2010
Celgene's Vidaza extends OS in MDS patients
8 June 2009
Celgene swings back to profit in 1st qtr
5 May 2009
Celgene falls up to 17% on low 1st-qtr forecast
3 April 2009
Celgene's Vidaza is first UK-approved MDS drug
9 March 2009
Celgene MDS drug cuts risk of death by 42%
2 March 2009
Celgene sales up 65% but falls to loss on costs
9 February 2009
Celgene reports initial 2008 figures
26 January 2009
Celgene's Vidaza approved in Europe
12 January 2009
High activity for Vidaza/Revlimid combo in Ph I MDS study
15 December 2008
Celgene's 3rd-qtr profit triples on drug sales
17 November 2008
Celgene's Vidaza gets expanded US indication
1 September 2008
Celgene profits double on rocketing sales
11 August 2008
EMEA accepts Vidaza for accelerated review
18 February 2008
Pharmion files Vidaza MAA with EMEA
21 January 2008
Pharmion/MethylGene begin combined MGCD0103/Vidaza trial
14 January 2008
Celgene's
14 January 2008
Pharmion's Vidaza achieves survival benefit in MDS
17 December 2007
Lymphoma drug gets EU Orphan Status
1 October 2007
US MDS Foundation welcomes Vidaza data
10 September 2007
Pharmion's oral azacitidine advances
30 April 2007
FDA accepts Pharmion's azacitidine IND
5 February 2007
FDA approves Pharmion's Vidaza for IV use
5 February 2007
Japan stock market week to Nov 27, 2006
4 December 2006
Pharmion grants Japanese Vidaza rights to Nippon Shinyaku
27 November 2006
TopoTarget and CuraGen begin dosing in blood cancer study
14 August 2006
Vidaza launch boost Pharmion's 4th qtr
21 February 2005
New product launches in 2004
31 January 2005
Pharmion's Vidaza sales $20.4M in launch quarter
1 November 2004
Pharmion raises sales guidance for Vidaza
4 October 2004
Pharmion launches Vidaza in the USA
12 July 2004
Pharmion's Vidaza gets FDA OK
24 May 2004
Priority Review for Pharmion's Vidaza
1 March 2004
Pharmion submits US NDA for Vidaza
5 January 2004
Pharmion placement raises $65 million
6 December 2001
Showing 1-46 of 46 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
